title: Where Do We Look for Markers of Radiotherapy Fraction Size Sensitivity?
abstract: The response of human normal tissues to radiotherapy fraction size is often described in terms of cellular recovery, but the causal links between cellular and tissue responses to ionising radiation are not necessarily straightforward. This article reviews the evidence for a cellular basis to clinical fractionation sensitivity in normal tissues and discusses the significance of a long-established inverse association between fractionation sensitivity and proliferative indices. Molecular mechanisms of fractionation sensitivity involving DNA damage repair and cell cycle control are proposed that will probably require modification before being applicable to human cancer. The article concludes by discussing the kind of correlative research needed to test for and validate predictive biomarkers of tumour fractionation sensitivity.
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: navita.somaiah@icr.ac.uk.
authors.forename: N
authors.initials: N
authors.lastname: Somaiah
authors.affiliation: University Medical Center, Hamburg-Eppendorf, Germany.
authors.forename: K
authors.initials: K
authors.lastname: Rothkamm
authors.affiliation: The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Yarnold
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D004260:DNA Repair; D019583:Dose Fractionation, Radiation; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D011836:Radiation Tolerance / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor
keywords: Cancer; DNA repair; fractionation; hypofractionation; normal tissues; radiotherapy